ADIM
SGEN

Alpha DNA Investment Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Alpha DNA Investment Management’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed – – 707
2021
Q1 		$0 Sell
2
-1,052
-100% -$170K ﹤0.01% 801
2020
Q4 		$184K Buy
+1,054
New +$197K 0.2% 106

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's SGEN Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Seagen Inc. Common Stock (SGEN) in Q2 2021, closing a stake of 2 shares.

Alpha DNA Investment Management first reported a position in SGEN in Q4 2020 and held it in 2 quarters. The position peaked at $184K in Q4 2020. 477 funds tracked by Wall St. Rank hold SGEN as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Seagen Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2 Seagen Inc. Common Stock shares in Q2 2021.
  • Alpha DNA Investment Management first reported a position in Seagen Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Seagen Inc. Common Stock position peaked at $184K in Q4 2020.
  • 477 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.